Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Bold Claims as GenapSys Opens Early Access to GENIUS

    Feb 19, 2014, 11:10 AM by Michael Croft
    Bio-IT World News Brief | Last week at AGBT 2014, GenapSys opened an early access program for researchers to test out the company's GENIUS sequencer, an instrument the size of a tablet that the company claims will be highly competitive on both speed and cost.
    Full story
  • Novel Encryption Scheme Aims to Secure Genetic Data

    Feb 19, 2014, 09:15 AM by Michael Croft
    ScienceNow | Kristin Lauter of Microsoft has demonstrated a new security scheme for genetic data that allows the data to be mined for information while still encrypted.
    Full story
  • Chas Bountra, Ph.D., to Give Keynote Presentation at CHI’s Structure-Based Drug Design Conference

    Feb 19, 2014, 00:00 AM by Michael Croft
    NEEDHAM, MA - Feb 19, 2014 - Cambridge Healthtech Institute (CHI) today announced Chas Bountra, Ph.D., Chief Scientist & Head of the Structural Genomics Consortium/University of Oxford, will give the keynote presentation at its 14th AnnualStructure-Based Drug Design conference scheduled for May 21-22, 2014 at the Westin Boston Waterfront, Boston, MA
    Full story
  • Ayasdi Continues Industry Accolades, Receives Four Major Innovation Awards

    Feb 19, 2014, 00:00 AM by Michael Croft
    PALO ALTO, CA  - Ayasdi (www.ayasdi.com) today announced that it has received four more major industry awards, bringing its total to nine milestone awards since the company launched in January 2013.
    Full story
  • iRODS Consortium welcomes UK’s Sanger Institute as newest member

    Feb 19, 2014, 00:00 AM by Michael Croft
    CHAPEL HILL, NC - Feb 19, 2014 - The iRODS Consortium today announced the Wellcome Trust Sanger Institute, a leading institution in the Human Genome Project now focused on understanding the role of genetics in health and disease, as its newest member
    Full story
  • Accelovance Continues Expansion with Opening of Research Triangle Park, North Carolina Office

    Feb 19, 2014, 00:00 AM by Michael Croft
    ROCKVILLE, MD, US - Accelovance, a therapeutically focused clinical research organization (CRO), announced today the opening of a new office in Research Triangle Park (RTP), North Carolina
    Full story
  • N-of-One and Appistry Announce Partnership

    Feb 18, 2014, 13:00 PM by Michael Croft
    Boston Business Journal | N-of-One and Appistry have partnered to more easily bring N-of-One's diagnostics plans to health care organizations.
    Full story
  • Rhenovia Pharma secures Series B funding

    Feb 18, 2014, 00:00 AM by Michael Croft
    MULHOUSE, FRANCE, CAMBRIDGE, MA - Rhenovia Pharma, a biotechnology company specialized in the application of biosimulation to the research and development of new medicinal products, today announces that it has raised EUR 540,000 (USD 738,000) from its historical shareholders in a second round of funding. 
    Full story
  • GenapSys Inc. Opens Early Access Registration for the World's First Pure Electronic DNA Sequencer - the GENIUS 110™

    Feb 18, 2014, 00:00 AM by Michael Croft
    REDWOOD CITY, CA - GenapSys Inc. unveiled the GENIUS 110™ Next Generation DNA Sequencing System at the AGBT (Advances in Genome Biology & Technology) sequencing technology conclave held on Marco Island, FL.  Dr. Hesaam Esfandyarpour, founder and ceo, presented the revolutionary GENIUS DNA sequencer with a footprint no bigger than an Apple® iPad® and that promises to make DNA sequencing widely available to individual researchers and diagnostic laboratories for the first time.
    Full story
  • Patient Stratification in Clinical Trials Emerges as Theme at MMTC

    Feb 17, 2014, 14:00 PM by Michael Croft
    Bio-IT World | The 21st annual Molecular Medicine Tri-Conference in San Francisco featured some intense scrutiny of one area where genetic knowledge is ready to make an impact today: better defining the best patient populations for treatment during clinical trials.
    Full story
  • eClipse Enterprise Solutions becomes ISO9001: 2008 certified continuing its commitment to high-quality service delivery

    Feb 17, 2014, 00:00 AM by Michael Croft
    EXETER, NH - eClipse Enterprise Solutions becomes ISO9001: 2008 certified
    Full story
  • Illumina Launches Genomics Accelerator

    Feb 13, 2014, 09:00 AM by Michael Croft
    Xconomy | Illumina is creating a genomics-focused accelerator at its Mission Bay R&D facility under construction in San Francisco.
    Full story
  • Crossing Continents: Mosaic Sample Management Software in Asia

    Feb 13, 2014, 00:00 AM by Michael Croft
    LONDON, UK - Titian Software (www.titian.co.uk) completes a highly successful 2013 with the announcement that its Mosaic sample management software has been installed at four major Contract Research Organisation (CRO) sites in China.
    Full story
  • TGen Physician-In-Chief Dr. Daniel Von Hoff inducted today into exclusive Joshua Lederberg Society

    Feb 13, 2014, 00:00 AM by Michael Croft
    PHOENIX, AZ - Dr. Von Hoff is honored for advancing FDA approved treatment benefiting pancreatic cancer patients  
    Full story
  • GenomOncology Announces Collaborations, Partnerships Before AGBT

    Feb 12, 2014, 10:00 AM by Michael Croft
    Bio-IT World | GenomOncology has announced several collaborations and partnerships surrounding its step-by-step workflow that takes raw data from the sequencer and translates the molecular profile of each patient’s tumor genome into an actionable clinical report. Recent partnerships include Roswell Park Cancer Institute, Vanderbilt-Ingram Cancer Center, University of Pittsburgh, and CompanionDx.
    Full story
  • QuantuMDx Launches MolDx Indiegogo Campaign

    Feb 12, 2014, 07:00 AM by Michael Croft
    Bio-IT World | QuantuMDx is taking their handheld molecular diagnostic tool to the masses, and hoping to raise $50,000 in an Indiegogo campaign starting today. The money will support a malaria clinical trial in Africa. 
    Full story
  • Terascala’s ISB Helps Solves High Performance Data Movement Challenges

    Feb 12, 2014, 00:00 AM by Michael Croft
    BOSTON, MA - Terascala, the fast data company, today announced that its Intelligent Storage Bridge (ISB), a high performance, scalable data mover, is an ideal solution for companies looking to optimize the daily movement of high performance computing (HPC) data in a variety of industries.
    Full story
  • AWS to Offer Enterprise R Package

    Feb 11, 2014, 08:00 AM by Michael Croft
    Computerworld | Amazon Web Services is now hosting R and offering it to users to run on AWS using the commercial package of R--Revolution R Enterprise 7.
    Full story
  • White Paper Points to Challenges and Solutions for Genomics in the Age of Big Data

    Feb 11, 2014, 00:00 AM by Michael Croft
    CHAPEL HILL, NC - Leading researchers in data science and genomics are recommending strategies to help genomic scientists better manage, share, analyze and archive massive research and clinical data sets in an effort to ensure that the big data explosion results in better health outcomes and faster research discoveries.
    Full story
  • TGen study uncovers possible genetic markers in breast cancer that spreads to the brain

    Feb 11, 2014, 00:00 AM by Michael Croft
    PHOENIX, AZ - The Translational Genomics Research Institute (TGen) has uncovered possible genetic origins of breast cancer that spreads to the brain, according to a first-of-its-kind study published in the scientific journal PLOS ONE.
    Full story
  • «
  • 401
  • 402
  • 403
  • 404
  • 405
  • 406
  • 407
  • 408 (current)
  • 409
  • 410
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy